Major human milk oligosaccharides are absorbed into the systemic circulation after oral administration in rats.
Human milk oligosaccharides (HMO) are involved in many biological functions influencing infant health. Although HMO act locally at the intestine, recent evidence has demonstrated that HMO are partially incorporated into the systemic circulation of breast-fed infants. In the last few years, a large amount of research has been conducted using preclinical models to uncover new biological functions of HMO. The aim of this study was to evaluate the absorption and urine excretion of HMO in rats. We administered a single oral dose of the following HMO: 2'-fucosyllactose (2'-FL), 6'-sialyllactose and lacto-N-neotetraose at different concentrations to adult rats. The time course of absorption of HMO into the bloodstream and their appearance in urine was studied. Our results showed that rats, similar to human infants, are able to effectively absorb a portion of HMO from the intestine into plasma and to excrete them in urine. On the basis of this, we also conducted a specific kinetic absorption study with 2'-FL, the most predominant HMO in human milk, in 9-11-d-old rat pups. Our results confirmed that a significant amount of 2'-FL was absorbed into the systemic circulation and subsequently excreted in urine during lactation in rats in a dose-depended manner. We also found basal levels of these HMO in plasma and urine of adult rats as well as rat pups as a natural result of nursing. Our data suggest that the rat may be a useful preclinical model that provides new insights into the metabolism and functions of HMO.
1Discovery R&D,Abbott Nutrition,18004 Granada,Spain.
E
E
Vazquez
1Discovery R&D,Abbott Nutrition,18004 Granada,Spain.
A
A
Santos-Fandila
2Discovery R&D,Abbott Nutrition,Columbus,OH 43219,USA.
R
R
Buck
1Discovery R&D,Abbott Nutrition,18004 Granada,Spain.
R
R
Rueda
1Discovery R&D,Abbott Nutrition,18004 Granada,Spain.
M
M
Ramirez
D000284:Administration, Oral; D000818:Animals; D001942:Breast Feeding; D004032:Diet; D004040:Dietary Carbohydrates / Q000097:blood / Q000493:pharmacokinetics / Q000652:urine; D005260:Female; D007408:Intestinal Absorption; D007422:Intestines; D007774:Lactation; D007785:Lactose / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics / Q000652:urine; D008297:Male; D008895:Milk, Human / Q000737:chemistry*; D009844:Oligosaccharides / Q000097:blood / Q000493:pharmacokinetics* / Q000652:urine; D017207:Rats, Sprague-Dawley; D014312:Trisaccharides / Q000097:blood / Q000493:pharmacokinetics* / Q000652:urine
C403777:6'-sialyllactose; D004040:Dietary Carbohydrates; D009844:Oligosaccharides; D014312:Trisaccharides; C013084:lacto-N-neotetraose; D007785:Lactose; C031420:2'-fucosyllactose
 2'-FL 2'-fucosyllactose;  3'-SL 3'-sialyllactose;  6'-SL 6'-sialyllactose;  HMO human milk oligosaccharides;  LNnT lacto-N-neotetraose; 2'-Fucosyllactose; 6'-Sialyllactose; Human milk oligosaccharides; Human milk oligosaccharides absorption; Rats